181 related articles for article (PubMed ID: 8542959)
1. Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance.
Philpott NJ; Scopes J; Marsh JC; Gordon-Smith EC; Gibson FM
Exp Hematol; 1995 Dec; 23(14):1642-8. PubMed ID: 8542959
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
Manz CY; Nissen C; Wodnar-Filipowicz A
Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in CD34+ cells by sera from patients with aplastic anemia.
Liu H; Mihara K; Kimura A; Tanaka K; Kamada N
Hiroshima J Med Sci; 1999 Jun; 48(2):57-63. PubMed ID: 10434475
[TBL] [Abstract][Full Text] [Related]
4. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
Timeus F; Crescenzio N; Doria A; Foglia L; Linari A; Giaccone M; Pastore G; di Montezemolo LC; Ramenghi U; Saracco P
Exp Hematol; 2005 May; 33(5):597-604. PubMed ID: 15850838
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
9. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
Chen G; Shao Z; Jia H
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy in bone marrow aplasia: the stroma functions normally to support hematopoiesis.
Novitzky N; Jacobs P
Exp Hematol; 1995 Dec; 23(14):1472-7. PubMed ID: 8542933
[TBL] [Abstract][Full Text] [Related]
11. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
[TBL] [Abstract][Full Text] [Related]
12. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
13. A probable role for trail-induced apoptosis in the pathogenesis of marrow failure. Implications from an in vitro model and from marrow of aplastic anemia patients.
Kakagianni T; Giannakoulas NC; Thanopoulou E; Galani A; Michalopoulou S; Kouraklis-Symeonidis A; Zoumbos NC
Leuk Res; 2006 Jun; 30(6):713-21. PubMed ID: 16310248
[TBL] [Abstract][Full Text] [Related]
14. Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.
Wodnar-Filipowicz A; Chklovskaia E; Manz CY; Lyman SD; Nissen C
Exp Hematol; 1997 Jul; 25(7):573-81. PubMed ID: 9216732
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
[TBL] [Abstract][Full Text] [Related]
16. The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.
Mundle S; Venugopal P; Shetty V; Ali A; Chopra H; Handa H; Rose S; Mativi BY; Gregory SA; Preisler HD; Raza A
Int J Hematol; 1999 Apr; 69(3):152-9. PubMed ID: 10222652
[TBL] [Abstract][Full Text] [Related]
17. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
18. CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity.
Mastrandrea F; Semeraro FP; Coradduzza G; Manelli M; Scarcia G; Pezzuto F; Serio G
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):90-103. PubMed ID: 19334373
[TBL] [Abstract][Full Text] [Related]
19. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
20. Expression of differentiation antigens and adhesion molecules on CD34+ cells in peripheral blood and bone marrow after chemotherapy followed by administration of granulocyte colony stimulating factor.
Masauzi N
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):771-83. PubMed ID: 8996844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
